V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20158812 | 20060879 | 1.56 | 52.85 | Curative (C) | 2018-04-08 | 2018-04-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101314069 |
| 20158813 | 20060880 | 1.61 | 47.5 | null | 2017-04-09 | 2017-04-19 | Gemcitabine + Capecitabine | null | null | ECX | 100592619 |
| 20158816 | 20060881 | 1.65 | 57.5 | Neo-adjuvant (N) | 2018-10-02 | 2018-10-11 | ECX | 2 | N | ECX | 100527941 |
| 20158817 | 20060882 | 1.67 | 69.7 | Neo-adjuvant (N) | 2016-02-27 | 2016-03-04 | ECX | 02 | N | ECX | 101819657 |
| 20158818 | 20060883 | 1.66 | 80.8 | Palliative (P) | 2018-05-27 | 2018-05-27 | ECX | N | N | ECX | 101130509 |
| 20158819 | 20060884 | 1.56 | 69.7 | Neo-adjuvant (N) | 2017-01-02 | 2017-01-09 | ECX | N | Y | ECX | 100898737 |
| 20158823 | 20060885 | 1.78 | 81 | Palliative (P) | 2016-06-03 | 2016-06-10 | ECX | 02 | N | ECX | 101037938 |
| 20158824 | 20060886 | 1.68 | 70 | Adjuvant (A) | 2016-02-12 | 2016-02-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100867239 |
| 20158825 | 20060887 | 1.7 | 68.3 | Neo-adjuvant (N) | 2019-06-11 | 2019-06-25 | ECX | N | N | ECX | 100641385 |
| 20158828 | 20060888 | 1.79 | 62.35 | Neo-adjuvant (N) | 2016-02-29 | 2016-02-29 | ECX | 2 | N | ECX | 101582303 |
| 20158829 | 20060889 | 1.83 | 46.8 | Palliative (P) | 2018-05-25 | 2018-05-25 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100403750 |
| 20158831 | 20060890 | 1.61 | 66 | Neo-adjuvant (N) | null | 2018-10-20 | ECX | N | N | ECX | 100314701 |
| 20158832 | 20060891 | 1.62 | 79.4 | Neo-adjuvant (N) | 2019-01-23 | 2019-02-03 | ECX | N | N | ECX | 100750364 |
| 20158834 | 20060892 | 1.56 | 77 | Adjuvant (A) | 2017-03-25 | 2017-04-07 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100807519 |
| 20158838 | 20060893 | 1.81 | 45 | Palliative (P) | 2019-08-07 | 2019-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101648623 |
| 20158840 | 20060894 | 1.68 | 75.8 | Palliative (P) | 2016-04-23 | 2016-04-23 | ECX | N | N | ECX | 100049747 |
| 20158841 | 20060895 | 1.8 | 77.3 | Neo-adjuvant (N) | 2016-09-26 | 2016-09-26 | ECX | N | N | ECX | 101237609 |
| 20158842 | 20060896 | null | null | Neo-adjuvant (N) | 2018-07-21 | 2018-07-21 | ECX | 2 | null | ECX | 101201332 |
| 20158844 | 20060897 | 1.71 | 65.3 | Curative (C) | 2017-06-23 | 2017-07-01 | ECX | N | N | ECX | 100263459 |
| 20158846 | 20060898 | 1.63 | 68.65 | Disease modification (D) | 2020-02-01 | 2020-02-01 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101120390 |
| 20158849 | 20060899 | 1.6 | 46.3 | Palliative (P) | 2016-05-20 | 2016-06-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100098786 |
| 20158850 | 20060900 | 1.5 | 111.2 | Palliative (P) | 2019-07-22 | 2019-08-05 | ECX | N | N | ECX | 101688267 |
| 20158851 | 20060901 | 1.6 | 75.7 | Adjuvant (A) | 2016-08-21 | 2016-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100914278 |
| 20158852 | 20060902 | 1.64 | 55.9 | Adjuvant (A) | 2016-09-15 | 2016-09-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100072483 |
| 20158853 | 20060903 | 1.75 | 48 | Neo-adjuvant (N) | 2017-02-27 | 2017-03-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101866304 |
| 20158854 | 20060904 | 1.85 | 63.2 | Curative (C) | 2019-07-02 | 2019-07-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100450511 |
| 20158855 | 20060905 | 1.5 | 73.8 | Adjuvant (A) | 2018-09-18 | 2018-10-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100521428 |
| 20158857 | 20060906 | 1.78 | 75 | Neo-adjuvant (N) | null | 2019-12-09 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100877140 |
| 20158858 | 20060907 | 1.8 | 67.15 | Palliative (P) | 2017-03-30 | 2017-03-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100903264 |
| 20158862 | 20060908 | null | null | Palliative (P) | 2019-08-05 | 2019-08-16 | ECX | 2 | null | ECX | 100667432 |
| 20158863 | 20060909 | 1.63 | 107 | Neo-adjuvant (N) | 2016-12-06 | 2016-12-14 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101480684 |
| 20158864 | 20060910 | 1.83 | 103.2 | Neo-adjuvant (N) | 2016-09-03 | 2016-10-02 | ECX | N | N | ECX | 101811935 |
| 20158865 | 20060911 | 1.76 | 84.4 | Curative (C) | 2017-04-25 | 2017-05-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101080608 |
| 20158866 | 20060912 | 1.7 | 62.2 | Neo-adjuvant (N) | 2020-01-23 | 2020-01-23 | ECX | N | N | ECX | 101850626 |
| 20158867 | 20060913 | null | null | Adjuvant (A) | 2018-08-19 | 2018-08-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101028915 |
| 20158868 | 20060914 | 1.67 | 83.3 | Palliative (P) | 2016-10-25 | 2016-10-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100957254 |
| 20158869 | 20060915 | 1.58 | 48.3 | Adjuvant (A) | 2017-01-16 | 2017-01-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101151304 |
| 20158870 | 20060916 | 1.76 | 119.8 | Neo-adjuvant (N) | 2018-05-19 | 2018-06-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101691893 |
| 20158871 | 20060917 | 1.68 | 55.9 | Adjuvant (A) | 2018-01-13 | 2018-01-26 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101720396 |
| 20158872 | 20060918 | 1.69 | 82.9 | Palliative (P) | 2019-02-05 | 2019-02-10 | ECX | N | N | ECX | 101120678 |
| 20158873 | 20060919 | 1.62 | 59.2 | Neo-adjuvant (N) | 2019-11-28 | 2019-12-09 | ECX | 02 | N | ECX | 100344101 |
| 20158874 | 20060920 | 1.57 | 89.9 | null | 2017-05-02 | 2017-06-10 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100763081 |
| 20158877 | 20060921 | 1.8 | 65.7 | null | 2016-11-26 | 2016-12-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101792011 |
| 20158879 | 20060922 | 1.65 | 53.2 | Adjuvant (A) | 2016-03-31 | 2016-04-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101859928 |
| 20158880 | 20060923 | 1.58 | 82.5 | Neo-adjuvant (N) | 2016-06-14 | 2016-06-22 | ECX | N | N | ECX | 101111540 |
| 20158881 | 20060924 | 1.7 | 72.6 | Palliative (P) | 2017-03-29 | 2017-04-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100781963 |
| 20158883 | 20060925 | 1.6 | 95.1 | Palliative (P) | 2017-05-17 | 2017-05-20 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101853725 |
| 20158887 | 20060926 | 1.75 | 77.6 | Curative (C) | 2017-06-01 | 2017-06-06 | ECX | N | N | ECX | 100697721 |
| 20158890 | 20060927 | 1.9 | 77 | Neo-adjuvant (N) | 2018-09-02 | 2018-09-17 | ECX | 2 | N | ECX | 101846860 |
| 20158891 | 20060928 | 1.57 | 66.8 | Neo-adjuvant (N) | 2018-12-18 | 2018-12-20 | ECX | N | N | ECX | 101464827 |